Telmisartan Research Guide

Full name: Telmisartan (ARB / Partial PPAR-gamma Agonist)

An FDA-approved angiotensin receptor blocker (ARB) for blood pressure that is a favorite in longevity circles because, unlike other ARBs, it also partially activates PPAR-gamma, giving it metabolic and mitochondrial benefits beyond blood pressure control.

How Telmisartan Works

Blocks the angiotensin II type 1 (AT1) receptor to lower blood pressure and reduce vascular inflammation, while also acting as a partial PPAR-gamma agonist that improves insulin sensitivity, lipid handling, and mitochondrial biogenesis.

Dosing Protocol

• Typical dose: 20-80 mg per day
• Frequency: Once daily
• Duration: Ongoing
• Route: Oral tablet

Reported Benefits

• Blood pressure control
• PPAR-gamma metabolic benefits
• Improved insulin sensitivity
• Vascular anti-inflammatory effects
• Cardio- and reno-protection
• 24-hour coverage

Potential Side Effects

• Dizziness/low blood pressure
• Hyperkalemia
• Rare kidney function changes
• Contraindicated in pregnancy
• Fatigue

Research Citations

1. Telmisartan PPAR-gamma activity (2018) - Uniquely among ARBs, telmisartan partially activated PPAR-gamma, improving insulin sensitivity and lipid profiles.
2. ONTARGET cardiovascular outcomes (2008) - Telmisartan was as effective as ramipril for reducing cardiovascular events with better tolerability.

Related Cardiovascular Compounds

• Nattokinase - Full Profile
• Serrapeptase - Full Profile
• CoQ10 - Full Profile
• Omega-3 (EPA/DHA) - Full Profile
• Bergamot Extract - Full Profile
• Vesugen - Full Profile

View full Telmisartan profile with 3D molecule viewer →